Apomorphine is reported to be an inhibitor of amyloid beta protein (Aβ) fiber formation and a potential therapeutic for Alzheimer's disease (AD) under the amyloid hypothesis.
The protective effects of apomorphine were tested in mouse models with mutations in genes related to AD, such as the amyloid precursor protein (APP) gene, which is implicated in amyloid molecule build-up.